Natco Pharma’s Partner Mylan Inc Gets USFDA Approval For Cancer Drug

Mylan Inc has received a tentative approval from the USFDA for abbreviated new drug application for Sorafenib tablets in the strength of 200 mg. New Delhi:¬†Natco Pharma on Friday said its marketing partner Mylan Inc has received tentative approval from the US health regulator for selling generic Sorafenib tablets used […]